Cardiovascular GLP-1 indication approval 2026: Both in 2026
46%YES chance
Yes
46%
No
54%
Now 46.4%
Resolution
Resolves to the first GLP-1 to win an additional cardiovascular indication from FDA in 2026.
Source: https://www.fda.gov/
Resolves by Apr 8, 2027.
Recent trades
- 9.4 sh@ 46%5 SP
- YES@rileykim10.7 sh@ 47%5 SP
- 10.8 sh@ 46%5 SP
- YES@sashavargas11 sh@ 46%5 SP
- 109 sh@ 44%58 SP
- 9.2 sh@ 45%5 SP
- YES@drewhayes11 sh@ 46%5 SP
- YES@tatumjensen11.1 sh@ 45%5 SP
- 10 sh@ 50%5 SP
- YES@drewhayes11.3 sh@ 45%5 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.